These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35467485)

  • 1. Computational studies reveal potential dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitors amidst existing drugs.
    Ibezim A; Osigwe S; Uzor P; Engel N; Ramanathan K; Nwodo N
    J Biomol Struct Dyn; 2023 Jul; 41(10):4811-4818. PubMed ID: 35467485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studies.
    Mitachi K; Kurosu SM; Gillman CD; Yun HG; Clemons WM; Kurosu M
    MethodsX; 2019; 6():2305-2321. PubMed ID: 31667130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 M
    Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
    J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
    Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
    J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
    Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
    J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential inhibitors for LLM of
    Kumari R; Dalal V
    J Biomol Struct Dyn; 2022; 40(20):9833-9847. PubMed ID: 34096457
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-based drug discovery by targeting
    Kurosu M
    Future Med Chem; 2019 May; 11(9):927-933. PubMed ID: 30907628
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.
    Mitachi K; Mingle D; Effah W; Sánchez-Ruiz A; Hevener KE; Narayanan R; Clemons WM; Sarabia F; Kurosu M
    Angew Chem Int Ed Engl; 2022 Aug; 61(31):e202203225. PubMed ID: 35594368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches.
    Jethwa M; Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
    Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
    Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of inhibition of COVID-19 main protease by β-adrenoceptor agonists and adenosine deaminase inhibitors using
    Venugopal PP; Chakraborty D
    J Biomol Struct Dyn; 2022 Jul; 40(11):5112-5127. PubMed ID: 33397209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring species-specific inhibitors with multiple target sites on
    Yuce M; Sarica Z; Ates B; Kurkcuoglu O
    J Biomol Struct Dyn; 2023 May; 41(8):3496-3510. PubMed ID: 35302925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic level and structural understanding of natural ligands inhibiting
    Sunder Raj D; Kesavan DK; Kottaisamy CPD; Kumar VP; Hopper W; Sankaran U
    J Biomol Struct Dyn; 2023 May; 41(8):3440-3461. PubMed ID: 35293845
    [No Abstract]   [Full Text] [Related]  

  • 17. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.
    Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK
    J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential inhibitors for FKBP51: an
    Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
    J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2.
    Varma DA; Singh M; Wakode S; Dinesh NE; Vinaik S; Asthana S; Tiwari M
    J Biomol Struct Dyn; 2023 Apr; 41(7):2956-2970. PubMed ID: 35196966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.